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the memory CD8+ T lymphocyte responses in chickens to AIV proteins have not been deﬁned, these
responses to H5N9 AIV hemagglutinin (HA) and nucleocapsid (NP) proteins were evaluated by ex vivo
stimulation with virus infected non-professional antigen presenting cells. Secretion of IFNγ by activated T
lymphocytes was evaluated through macrophage induction of nitric oxide. AIV speciﬁc, MHC-I restricted
memory CD8+ T lymphocyte responses to NP and HA were observed 3 to 9 weeks post-inoculation (p.i.). The
responses speciﬁc to NP were greater than those to HA with maximum responses being observed at 5 weeks
p.i. followed by a decline to weakly detectable levels by 9 weeks p.i. The cross-reaction of T lymphocytes to a
heterologous H7N2 AIV strain demonstrated their ability to respond to a broader range of AIV.isson).
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Avian inﬂuenza viruses (AIV) within the Orthomyxoviridae family
have segmented, negative sense RNA genomes. These viruses, natural
infectious agents of waterfowl and shorebirds, are classiﬁed according
to their transmembrane hemagglutinin (HA) and neuraminidase (NA)
glycoproteins (Alexander, 2000; Krauss et al., 2007; Olsen et al., 2006;
Webby and Webster, 2001). Due to their incredibly broad avian host
range, AIV strains have been isolated from many different species of
birds including ducks, gulls, geese, psittacines and poultry (Alexander,
2000; Olsen et al., 2006). AIV strains with all 16 hemagglutinin (HA)
and 9 neuraminidase (NA) types have been isolated from waterfowl
or shore birds (Fouchier et al., 2005; Krauss et al., 2007). Depending
on the virulence of the virus in poultry, isolates from poultry are
classiﬁed as either low pathogenic (LP) or highly pathogenic (HP)
(Alexander, 2000; Collisson et al., 2008). LPAIV strains cause
asymptomatic to mild respiratory and enteric tract infections while
the highly pathogenic strains cause clinical illness and systemic
infections. Infections of poultry, especially with the highly pathogenic
strains, result in severe economic losses (Capua and Marangon, 2003;
Tollis and Di Trani, 2002). Human inﬂuenza viruses, including thosecausing high morbidity and signiﬁcant mortality, such as the H1N1
from 1918, H2N2 from 1957 and H3N2 from 1968 have been shown to
have avian origins (Capua and Alexander, 2002; Taubenberger et al.,
2001). Even the currently circulating swine origin H1N1 human
inﬂuenza virus encodes two genes of AIV origin (Babakir-Mina et al.,
2009; Garten et al., 2009). Since 1996, highly pathogenic H5N1 AIV
strains isolated in Hong Kong have been infecting and subsequently
causing deaths in humans, although person-to-person transmission is
apparently rare (Capua and Alexander, 2002; Perdue and Swayne,
2005; Ungchusak et al., 2005). Poultry is a logical intermediate host
for adaptation of viral strains from wild birds to humans and other
mammals, such as swine (Webby andWebster, 2001;Webster, 1997).
Indeed, human adapted strains have been shown to consist of genome
segments of avian, swine and human origin (Webby and Webster,
2001; Webster, 1997).
Vaccination efﬁcacy is traditionally determined by the demon-
stration of protective humoral immunity, especially targeting AIV HA
and by putative neutralization of viruses (Collisson et al., 2008; Suarez
et al., 2006; Swayne and Kapczynski, 2008). While sterile immunity
may depend on humoral responses to homologous HA, effector and
memory CD8+ T cell immunity in mice has been shown to diminish
disease preventing mortality, and even morbidity (Rimmelzwaan
et al., 2007; Swain et al., 2004). Humoral immunity of chickens to AIV
is well characterized but little information is available regarding the
more difﬁcult to evaluate, viral speciﬁc T cell immune responses
(Kwon et al., 2008; Seo and Webster, 2001; Swayne and Kapczynski,
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characterization in mice is based only on mouse adapted viruses. It is
relevant to deﬁne the T lymphocyte mediated immune responses in
chickens since AIVs are established pathogens of poultry and can be
transmitted directly from chickens to humans.
Avian T lymphocytes have been stimulated ex vivo with MHC
matched chicken kidney cells (CKC) serving as non-professional
antigen presenting cells (APCs) and by the adoptive transfer of MHC
matched T lymphocytes to naïve chicks prior to viral challenge (Pei
et al., 2003; Seo et al., 2000). The availability of a number of poultry
lines with deﬁned MHC (located within the chicken B locus) greatly
facilitates the evaluation of the adaptive T lymphocyte responses in
chickens (Miller et al., 2004). Studies targeting acute infections with
a strain of infectious bronchitis virus (IBV), an avian coronavirus,
have identiﬁed speciﬁc CD8+ T cell responses (Seo and Collisson,
1997). Adoptive transfer of either effector T cells prepared from birds
10 days post-infection (p.i.) or of memory T lymphocytes prepared
from birds 3 weeks after infection with IBV, provided protection
against acute disease after viral challenge (Pei et al., 2003; Seo et al.,
2000). Following infection with H9N2 AIV, Seo et al. (2002)
described CD8+ T cell responses that correlated with cross-
protection to an H5N1 strain. Protection by effector CD8+ T
lymphocytes prepared at 7 to 10 days p.i. with AIV was demonstrat-
ed following adoptive transfer 1 day prior to AIV challenge (Seo and
Webster, 2001). However, none of these studies with AIV identiﬁed
the individual AIV proteins housing T lymphocytes epitopes or
described the kinetics of the T lymphocyte mediated memory
responses to AIV.
This current study describes the memory responses of peripheral
blood T lymphocytes from chicks to AIV HA and/or NP protein. DNA
plasmid vectors expressing AIV proteins were used to delineate the
responses induced individually by either HA or NP proteins.
Responses were evaluated following ex vivo stimulation with MHC-I
matched or mismatched APCs. Both NP and HA induced AIV speciﬁc
memory T lymphocyte responses between 3 and 9 weeks p.i.
Although the T lymphocyte response induced by NP was greater
than the response induced by HA until 7 weeks p.i., no differences
between the responses to the two proteins were detected by 9 weeks
p.i. The maximum response of memory T lymphocytes against either
AIV NP or HA protein was observed at 5 weeks p.i.
Results
In vitro expression of AIV proteins
In order to determine the T lymphocyte responses to individual
AIV proteins, the NP and HA genes of the low pathogenic H5N9
(Turkey/Wis/68) strainwere cloned into the pcDNA3.1/V5-His-TOPO
TA vector (Invitrogen, Carlsbad, CA). The eukaryotic expression of the
proteins encoded by the plasmids was determined by IFA in CHO-K1
cells 48-h post-transfection with plasmids expressing either NP or HA
(Fig. 1). No ﬂuorescence was observed in cells transfected with
plasmid encoding for LacZ.
Humoral immune response to AIV proteins
The in vivo expression of AIV HA and NP and the antibody response
to these proteins in the chickens was conﬁrmed by detecting the
presence of antibodies speciﬁc for HA and NP at 3 weeks p.i. with the
plasmids. HI titers of sera from 6 chickens inoculated with the HA
expression plasmid using the homologous strain ranged from 5 to 6.5
log2 (GMT). Sera from chickens inoculated with HA plasmid failed to
inhibit hemagglutination by a heterologous H7N2 AIV. No HI activity
was detected in sera of the 4 chickens inoculatedwith PBS. ELISA titers
for antibodies against NP in 6 NP plasmid inoculated chickens ranged
between 2.5 and 3.0 log10 (GMT) at 3 weeks p.i. (Fig. 2).Memory T cell responses were detected from weeks 3 to 9 p.i. with HA
and NP plasmids
Because the T cell speciﬁcity for individual AIV proteins have
not previously been reported in chickens, T lymphocyte responses
to HA, NP or a combination of both HA and NP (HN) were
determined following inoculation of B19/B19 chickens with
plasmids expressing the HA or NP ORF. In the absence of well-
established ELISA or intracellular cytokine staining methods to
examine avian T lymphocyte mediated responses an indirect IFNγ
assay (NO production from HD11 cells, a chicken macrophage cell
line) was precisely standardized for evaluating the ex vivo
activation of T lymphocytes by APCs. CKC infected with AIV were
used as non-professional APCs for the stimulation of T lymphocytes.
As demonstrated in other studies, the primary effector T lympho-
cyte response observed at 10 days p.i. had declined to basal level
by 16th day p.i. (data not shown).
Considering previously conducted adoptive transfer studies, which
identiﬁed speciﬁc memory T cells to IBV by 3 weeks p.i. with maximal
responses occurring between weeks 5 and 6 p.i. (Pei et al., 2003), the
memory AIV response of peripheral blood memory T lymphocytes
were also evaluated between 3 and 9 weeks p.i. with HA, NP, or HN
plasmids. The kinetics of the T lymphocyte mediated responses was
determined on the same birds during the course of the study. All data
represent the response from individual birds.
Following ex vivo co-culture with MHC matched B19/B19 APCs
infected with H5N9 virus, memory responses were detected in T cell
preparations obtained from all chickens receiving plasmids expres-
sing either AIV protein by 3weeks p.i. Since neither supernatants from
the T cells cultured with uninfected APCs nor T cells from PBS
inoculated birds cultured with infected MHC matched B19/B19 birds
produced IFNγ (data not shown), the memory T lymphocyte activity
was considered AIV speciﬁc. The ex vivo stimulation of the T cells from
plasmid inoculated birds with MHC mismatched B2/B2 APCs could
only induce basal levels of NO (Fig. 3), indicating the memory T
lymphocyte responses from each group of chickens receiving AIV
plasmids was highly MHC restricted.
The maximum memory T cell responses to NP were detected at
5 weeks p.i. However, while still detectable, memory T cells responses
at 9 weeks p.i, were dramatically diminished for all birds receiving the
AIV expression plasmids (HA, NP or HN). During weeks 3 through 7,
the activity of T cells from the HA plasmid inoculated birds was
signiﬁcantly less than that of T cells isolated from birds receiving
either NP or NP plus HA plasmids (Fig. 3). In addition to weaker APC
induced stimulation, the levels of HA speciﬁc memory T lymphocyte
responses were similar at weeks 3, 5 and 7 p.i. These results were
observed for two independent experiments.
CD8+ T lymphocyte populations increase with ex vivo stimulation
The phenotype of activated subpopulations of T lymphocytes
following co-culture with APCs expressing AIV antigens was
determined using ﬂow cytometric analyses (Table 1). In order to
evaluate the type of T lymphocyte population expanding in
response to infected APCs, the proliferation of the lymphocytes
from chickens inoculated with both NP and HA (HN) plasmids was
determined at 5 weeks p.i. Lymphocyte populations were gated
using a chicken pan lymphocyte CD44 speciﬁc MAb and MAbs
speciﬁc for either CD4 or CD8 T cell antigens (Seo and Collisson,
1997). The relative increases in the populations of CD8+ T
lymphocytes harvested from each HA and NP (HN) plasmid
inoculated chicken were between 62% and 91% following ex vivo
stimulation with AIV expressing APCs, in contrast to the increase of
31% to 37% in the CD4+ T lymphocyte populations. The increase in
the population of T lymphocytes harvested from PBS inoculated
birds was 7% and 1% for CD8+ and CD4+ T lymphocyte
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APCs. The preferential increase in CD8+ cells correlates with their
anticipated expansion following exposure to non-professional APCs
endogenously expressing AIV and expressing surface MHC-I.
Responding T cells cross react with a heterologous H7N2 AIV strain
A rationale for targeting cellular immunity is the potential for
cross-reactivity between vaccine and heterologous virus. Since the
availability of the peripheral T lymphocytes was limited and the same
birds were being used throughout the study, all aspects of the
memory T lymphocyte mediated responses could not be evaluated at
same time points. At 8 weeks p.i. the capacity for memory T
lymphocytes speciﬁc for the NP and HA proteins of the H5N9 strain
to be stimulated with an H7N2 (A/Turkey/Virgina/158512/02) strain
of AIV was determined following co-culture with MHC matched APCs
infected with either AIV strain (Fig. 4). Both heterologous H7N2 and
homologous H5N9 AIV infected APCs signiﬁcantly stimulated IFNγ
production from memory T lymphocytes isolated from either HA or
NP inoculated chickens (p≤0.01) compared with PBS inoculated
chickens. Regardless of the strain used to infect APCs, the observed
memory responses generated by T cells obtained from chickens
receiving the NP plasmid were again statistically greater (p≤0.008)
than that generated by T cells harvested from HA plasmid inoculated
chickens.
Similar memory T lymphocyte responses were observed with low
pathogenic AIV infection
Memory T cells could be readily detected between 3 and 7 weeks
p.i. with plasmids expressing either the NP or the HA proteins. In
order to evaluate the memory T lymphocyte responses of chickens
inoculated with infectious AIV, chicks with the B19/B19 haplotype
were inoculated with the low pathogenic H5N9/Turkey/Wis/68
strain and blood was collected at 5 weeks p.i. The ex vivo activation of
T lymphocytes by AIV infected APCs was determined by the indirect
IFNγ assay (Fig. 5). The mean average NO production induced by the
ex vivo stimulation of T lymphocytes from infected birds with B19/
B19 APCs was speciﬁc compared with the uninfected, MHC matched
APCs (p≤0.005). The responses to AIV infected APCs were MHC
restricted as demonstrated by only basal level activation by B2/B2
APCs.
Flow cytometric analysis was used to determine the phenotype of
the T lymphocyte subpopulations from the infected chickens
responding to ex vivo stimulation. The relative increase in the
population of CD8+ T lymphocytes from H5N9 infected chickens
was 46% to 95% while the increase in the CD4+ T lymphocyte
population ranged from 6 to 28% following co-culture with MHC-I
matched, H5N9 AIV infected APCs (Table 2). The increase in the
population of the lymphocytes from uninfected chickenswas only 1 toFig. 1. In vitro expression of pcDNA3.1/V5-His-TOPO TA vectored AIV proteins in transfect
positive reference serum as the source of primary antibodies. Cells were transfected with p14% and 10 to 19% for CD8+ and CD4+ T lymphocytes, respectively.
Although increases were observed in the CD4+ lymphocytes, the
greater increased proliferation of CD8+ lymphocytes from birds
infected with the low pathogenic virus was consistent with detection
of a preferential MHC-I restricted AIV speciﬁc, CD8+ memory T cell
response.
Discussion
This is the ﬁrst study delineating the response of chicken memory
CD8+ T lymphocytes to speciﬁc AIV proteins. Studies evaluating the
CD8+ T lymphocyte response to inﬂuenza virus in mice have
identiﬁed NP as housing the dominant CD8+ T cell epitopes (Flynn
et al., 1998; Kreijtz et al., 2007; O'Neill et al., 2000; Townsend et al.,
1984; Yewdell et al., 1985). In contrast, human cytotoxic T
lymphocytes (CTL) have a broader repertoire and the response is
directed to multiple inﬂuenza viral proteins, including HA (Gianfrani
et al., 2000; Gotch et al., 1987; Jameson et al., 1998; Kedzierska et al.,
2006; Kreijtz et al., 2008). This study has shown that similar to the
responses in humans, memory CD8+ T lymphocytes in chickens are
directed against both AIV HA and NP proteins (Gianfrani et al., 2000;
Jameson et al., 1998; Kreijtz et al., 2008; McMichael et al., 1986b).
Signiﬁcantly greater responses were induced by NP than by HA at 3
and 5weeks p.i. The AIV speciﬁc T cell responses were primarilyMHC-
I restricted as non-professional APCs of B19 and B2 haplotypes were
used for ex vivo stimulation of T cells and the APCs of B2 haplotype
chickens either failed to stimulate or could only weakly stimulate the
T lymphocytes derived from the B19 line. Therefore, responding T
cells were primarily of the CD8+ phenotype, which also showed
signiﬁcantly greater proliferation than CD4+ T lymphocytes in
response to ex vivo APC mediated stimulation. Similar to the MHC-I
restricted T lymphocyte responses demonstrated following infection
with IBV, CD8+ T cell memory responses to AIV HA and/or NP were
detected by 3 weeks p.i. (Pei et al., 2003). Preliminary studies in our
lab have also demonstrated an elevation in the levels of expression of
CD44 molecule on the surface of the responding T lymphocytes.
Greater CD44 expression has been described to be a characteristic of
mouse and human memory T lymphocytes (Curtsinger et al., 1998).
The current studies quantiﬁed the protein speciﬁc T lymphocyte
responses of the same birds until 9 weeks p.i. The responses increased
from 3 weeks p.i. until 5 weeks p.i. However, by 9 weeks p.i. with
plasmids expressing either NP or HA AIV protein, the memory T cell
activity had declined to signiﬁcantly lower levels. The decline in the
more vigorous CD8+ T lymphocyte response to NP was more rapid
after 5 weeks than the CD8+ T cell response stimulated by HA, such
that by 9 weeks p.i. the responses to both proteins individually or in
combination were similar. A decline in the CD8+ T lymphocyte
mediated protection at 10 weeks after challenge of H9N2- infected
chicks with H5N1 had been observed by Seo and Webster (2001).
Similarly, a decline in the memory T lymphocyte response speciﬁc toed CHO-K1 cells (magniﬁcation, 200×). Expression was detected by an IFA using AIV
lasmids expressing (A) LacZ, (B) HA, and (C) NP.
Fig. 2. Antibody titers induced in individual birds (n=6) by NP and HA expressing
plasmids at 3 weeks p.i. (A) Serum HI antibody titers from chickens inoculated with HA
expressing plasmid against the homologous H5N9 AIV strain and heterologous H7N2
AIV strain. (B) Serum anti-NP antibody ELISA titers from chickens inoculated with the
NP expressing plasmid. Neither HI nor anti-NP antibodies were detectable in the sera of
4 control birds inoculated with PBS. Each symbol represents the response of an
individual chicken.
Fig. 3. Chicken memory T lymphocyte responses to AIV HA and NP proteins between 3
and 9weeks p.i. with NP and/or HA expression plasmids. Chickens of the B19/B19MHC
haplotype were inoculated with DNA plasmids expressing AIV HA, NP or both HA and
NP (HN). Memory T lymphocytes were stimulated ex vivowith H5N9 AIV infected MHC
matched B19/B19 and mismatched B2/B2 APCs. Production of NO by HD11
macrophage cells induced by the secretion of IFNγ from stimulated T lymphocytes
was used to quantify lymphocyte activation. Results represent the average (±S.E.) of
two separate experiments. Each ex vivo stimulation assay is denoted by the source of T
lymphocytes and MHC haplotype of the APCs infected with the virus. The differences in
stimulation by matched and mismatched APCs were signiﬁcant (p≤0.003 to 0.02) for
each inoculated antigen and time point. The responses to HN (p≤0.03) at 3 weeks and
NP (p≤0.03) and HN (p≤0.007) at 5 weeks p.i. were signiﬁcantly greater than the
responses to HA at the same time points. The p value for the difference between
responses to NP and HA at 3 weeks p.i. was 0.07.
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chael et al., 1983).
Furthermore, our study also proved the efﬁcacy of the plasmid
delivery approach in providing a mechanism to evaluate the T cell
response to AIV HA and NP proteins, either individually or in
combination. Protection studies were not included following inocu-
lation of the AIV plasmids because of increased biosafety require-
ments for AIV. However, hemagglutinating antibodies which can be
correlated with protection were demonstrated (Toro et al., 2007). The
antibodies speciﬁc for the HA cloned from a H5N9 virus failed to
prevent H7N2 virus-mediated hemagglutination.
Since each ex vivo stimulation assay required speciﬁc numbers of
necessary controls for the validity of the results of the assay and
availability of limited numbers of T lymphocytes for each time, all
assays could not be conducted at the same time point. Although at
8 weeks p.i. the response of the memory T lymphocytes was
signiﬁcantly lower than the response at 5 weeks p.i., it remained
detectable and the APCs infected with H7N2 AIV were able to
effectively ex vivo stimulate the T lymphocytes from H5 inoculated
chickens. These observations indicate that despite the absence of
shared HI antibody epitopes, HA does have at least one CD8+ epitope
that is shared between both strains of the virus.
Adoptive transfer studies of CD8+ T lymphocytes speciﬁc for
IBV and AIV have demonstrated their importance in protection
against heterologous viruses (Pei et al., 2003; Seo et al., 2000; Seoand Webster, 2001). In mice, adoptive transfer of memory CD8+ T
lymphocytes speciﬁc for inﬂuenza virus NP has also been shown to
be protective against viral challenge (Lukacher et al., 1984; Taylor
and Askonas, 1986). In vivo inoculation of chicks with a DNA
plasmid expressing the IBV nucleocapsid protein was shown to
provide CTL mediated protection against acute respiratory disease
(Seo et al., 1997). Consistent with the greater response to NP from
the homologous virus, T lymphocytes of chicks inoculated with NP
exhibited greater cross reactivity with the heterologous H7N2 virus
than T cells from the birds inoculated with HA. The amino acid
sequences in HA from the two AIV strains were 41% identical
while the amino acid sequences of NP were 97% identical. The
more conserved nature of NP, in comparison to HA could be
responsible for the greater cross reactive response (Portela and
Digard, 2002). Although the variation could also be attributed to
the differences in the amount of antigen generated and presented
by the infected APCs (Busch and Pamer, 1998; Crowe et al., 2003;
Deng et al., 1997; Doherty et al., 1994), both NP and HA responses
were similar by 9 weeks p.i. using the same standardized cell
assay.
The differences in the repertoire of T cell epitopes along with the
variations in the binding afﬁnity of T cell epitopes withMHC-I can also
contribute to the differences in the CD8+ T cell mediated response to
inﬂuenza viral proteins (Cao et al., 1996; McMichael et al., 1986a).
Chickens have 27 distinct deﬁned MHC haplotypes (Miller et al.,
2004). Further studies aimed at determining the response to AIV
proteins in different MHC lines of chickens is important for
identiﬁcation of immunodominant proteins which can elicit con-
served CD8+ T lymphocyte responses amongst various MHC
haplotypes.
Although the cross reactivity of memory CD8+ T lymphocytes may
not prevent the infection of chickens with a heterotypic strain of AIV,
it could contribute to the more rapid clearance of the virally infected
cells and augment the protection against clinical illness. This study
establishes that chickens CD8+ T lymphocytes respond to AIV NP and
HA proteins. The ability of the other AIV proteins to stimulate CD8+ T
Table 1
Proliferation of T lymphocytes from birds 5 weeks p.i. with plasmids expressing HA and NP using ﬂow cytometry.a
Bird no. Inoculab CD4+ T lymphocytes (% of T cells) CD8+ T lymphocytes (% of T cells)
Uninfectedc Infectedd % Increasee Uninfected Infected % Increase
1 HA+NP 47.8 65.1 36 20.0 36.4 81
2 HA+NP 44.0 59.5 35 24.7 47.1 91
4 HA+NP 41.3 56.6 37 27.0 43.7 62
5 HA+NP 46.0 60.5 31 22.6 40.4 79
7 PBS 53.8 60.8 1 22.4 24.0 7
a Data representative of 2 experiments.
b HA+NP-Birds inoculated with 500 μg plasmids expressing HA and NP (HN) or PBS only.
c Population of T lymphocytes after stimulation with uninfected APCs.
d Population of T lymphocytes after stimulation with infected APCs.
e Increase in the population of T lymphocytes following stimulation by APCs expressing AIV.
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would also analyze the expression of various cytokines by the
activated T lymphocytes. Inclusion of AIV protein targets that can
induce cross reactive CD8+ T lymphocyte responses in addition to
humoral immunity in chickens is critical for the development of
efﬁcacious vaccines which can provide protective immunity against a
broader range of AIV types.
Materials and methods
Viruses
Low pathogenic AIVs, H5N9 (A/Turkey/Wis/68) and H7N2 (A/
Turkey/Virginia/158512/02), were propagated in the allantoic sacs of
10-day-old embryonated chicken eggs (ECE). The allantoic ﬂuid was
harvested 48 h p.i. and the presence of virus was veriﬁed by an
hemagglutination activity (HA) test according to the OIE guidelines
(http://www.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.
pdf). Viruses were quantiﬁed by titrating in ECE and expressed as
embryo infectious dose 50 (EID50) (Beard, 1989).
Experimental animals
Embryonated eggs of MHC deﬁned B19/B19 and B2/B2 lines of
chickens were obtained from Dr. Briles' laboratory at Northern Illinois
University (DeKalb, IL). After hatching, chicks were housed in a
speciﬁc pathogen-free environment at the vivarium facility, Western
University of Health Sciences, Pomona, CA. Viral infection studies in
chickens were conducted at the biosafety level 2 Lab Animal Research
Resource animal facility, Texas A&M University, College Station, TX.
All procedures involving the use of chickens were approved by andFig. 4. T lymphocytes from B19 birds inoculated with either H5N9 derived HA or NP
expression plasmids respond to a heterologous (H7N2) virus. At 8 weeks p.i., T
lymphocytes from chickens receiving either HA or NP cloned from the H5N9 strain
were co-cultured with APCs infected with H5N9 or H7N2 viruses. The T cell responses
are expressed as the average (±S.E.) of NO production for each treatment group. T
lymphocytes from plasmid-inoculated chickens had signiﬁcantly greater responses to
H7N2 AIV strain than those from the PBS control group (p≤0.01). PBMCwere prepared
from three individual chickens for each stimulation assay.conducted according to guidelines established by the Institutional
Animal Care and Use Committees of Western University of Health
Sciences and/or Texas A&M University.
Cloning of NP and HA into a eukaryotic expression plasmid
RNA from H5N9 (A/Turkey/Wis/68) was extracted from allantoic
ﬂuid using the RNeasy Mini kit (Qiagen, Valencia, CA) according to the
manufacturer's protocol. First strand cDNA was synthesized with
ImProm-II™ Reverse Transcriptase enzyme (Promega, Madison, WI)
usingAIV speciﬁcUniversal 12 primer (5′AGCA/GAAAGCAGG3′)(Urabe
et al., 1993). PFU polymerase (Stratagene, La Jolla, CA) was used to
amplify the open reading frames (ORF) of HA and NP using speciﬁc
primer pairs HA-Forward 5′-ACCATGGAAAGAATAGTGATT-3′and HA-
Reverse 5′-GATGCAAATTCTGCA-3′ and NP-Forward 5′-ACCAT-
GGCGTCTCAAGGCACC-3′ and NP-Reverse 5′-ATTGTCATACTCCTCTGC-
3′, respectively. Taq DNA polymerase (New England Biolabs, Ipswich,
MA) was then used to add TA overhangs on the PFU ampliﬁed PCR
product. The ampliﬁed cDNA products were cloned into the eukaryotic
expression vector pcDNA3.1/V5-His-TOPO TA (Invitrogen, Carlsbad,
CA). Big Dye terminator v1.1cycle sequencing kit (Applied Biosystems,
Foster City, CA)was used to sequence the cloned gene segments and the
sequence analysis was performed at GenoSeq, UCLA, Los Angeles, CA.
Following conﬁrmation of the sequence of the ORFs, in vitro expression
of NP and HA proteins were determined using an indirect immuno-
ﬂuorescence assay (IFA) on CHO-K1 cells transfected with the plasmids
expressing AIV proteins. Known chicken serum, positive for AIV (NVSL,
Ames, IA) was used at a dilution of 1:100 as primary antibody. Mouse
anti-chicken IgG FITC at a dilution of 1:500 (Southern Biotech,
Birmingham, AL) was used as the secondary antibody.Fig. 5. In vivo infection of B19 chickens with the low path H5N9/Tur/Wis/68 AIV
generates AIV speciﬁc, MHC matched memory T lymphocytes. The potential for
infectious AIV to also produce a memory T lymphocyte response was determined
5 weeks p.i. with H5N9. Mean (±S.E.) NO production by each treatment group is
represented by the bars. APCs used for ex vivo stimulation were either uninfected
(Uninf) or virus-infected (Inf). Signiﬁcantly lower (p≤0.01) NO production by AIV
infected mismatched APCs derived from the CKC of homozygous B2 chicks compared to
matched APCs derived from CKC of homozygous B19 chicks indicate MHC restriction. T
lymphocytes from three individual birds were used for each ex vivo stimulation assay.
Table 2
Proliferation of T lymphocytes from birds 5 weeks p.i. with AIV using ﬂow cytometry.
Bird no. CD4+ T lymphocytes (% of T cells) CD8+ T lymphocytes (% of T cells)
Uninfecteda Infectedb % Increasec Uninfected Infected % Increase
I-1d 40.7 52.1 28 16.3 31.7 95
I-2 48.3 58.4 21 12.1 20.5 69
I-3 49.6 60.9 23 17.8 25.9 46
I-4 55.9 59.5 6 18.5 31.7 71
I-5 43.9 53.6 22 9.55 18.5 94
C-1e 42.5 50.7 19 27.9 28.1 1
C-2 39.2 43.1 10 10.8 12.3 14
a Population of T lymphocytes after stimulation with uninfected APCs.
b Population of T lymphocytes after stimulation with infected APCs.
c Increase in the population of T lymphocytes following stimulation with APCs
expressing AIV.
d I—Chickens infected with H5N9/Turkey/Wis/68 AIV.
e C—Control chickens inoculated with PBS.
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Primary CKC lines were established from 10-day-old chicks of
B19/B19 and B2/B2MHC haplotype lines as described previously (Seo
and Collisson, 1997). CKC of the tenth passage were infected with AIV
and used as non-professional APCs for the stimulation of the CD8+ T
lymphocytes. The presence of MHC-I on CKC lines and the absence of
MHC-II was conﬁrmed by ﬂow cytometric analysis, using anti-chicken
MHC-I or anti-chicken MHC-II R-phycoerythrin conjugated mono-
clonal antibodies (MAbs) (Southern Biotech, Birmingham, AL) (data
not shown).
Inoculation of birds
Three-week-old speciﬁc, pathogen-free chickens of the B19/B19
MHC haplotype were inoculated, intramuscularly (i.m.), with 500 μg
of cDNA expressing HA alone or NP alone, or of 500 μg of each HA and
NP (HN) combined. Control birds were inoculated with either pcDNA
3.1 vector expressing LacZ (LacZ) or PBS. For viral inoculations, B19/
B19 chicks were inoculated at 3 weeks of age, intranasally, with 108
ELD50 of the low pathogenic H5N9/Tur/Wis/68 AIV strain.
AIV-speciﬁc antibody titrations
Serum sampleswere prepared fromblood collected from the jugular
vein of chickens at 3 weeks p.i. to evaluate the humoral responses
against AIV HA and NP. Hemagglutination inhibition (HI) assays, accor-
ding to OIE guideline (http://www.oie.int/eng/normes/mmanual/
2008/pdf/2.03.04_AI.pdf), were used to identify antibodies speciﬁc to
H5N9 virus (A/Turkey/Wis/68) HA. HI mediated by the anti-H5
antibodies against H7N2 AIV was also evaluated. Titers were expressed
as geometricmean titers (GMT). Titers of≤1 log2were assigned a titer of
1 log2. NP speciﬁc antibodies were determined using the AIV Plus ELISA
kit (Synbiotics, Kansas City, MO) as described by the manufacturer.
Effector cell preparation
Effector T lymphocytes used for ex vivo stimulation were prepared
fromperipheral bloodmononuclear cells (PBMC) from2 to 4 individual
chickens per group (Pei et al., 2003). Brieﬂy, blood was collected from
the jugular vein at 3, 5, 7 and 9 weeks p.i. and diluted 1:2 in Alsever's
solution (Sigma-Aldrich, St. Louis, MO). PBMCwere prepared by Ficoll-
histopaque (Histopaque-1077, Sigma-Aldrich, St. Louis, MO) density
gradient centrifugation (Seo and Collisson, 1997). Viable cells were
collected from the interface andwashed twicewithphosphate buffered
saline (PBS, pH 7.4). Cells were resuspended in 3 ml of RPMI 1640
(Invitrogen, La Jolla, CA) supplemented with 10% fetal bovine serum
(Gemini Bio-Products, West Sacramento, CA), 2 mM L-glutamine, and
0.1mMMEMnon-essential amino acids. B lymphocyteswere removedby passing the cell suspension through complete RPMI equilibrated
nylonwool column and adherent cells were removed by incubating the
cell preparation in 25 cm2 tissue culture ﬂasks as described previously
(Seo andCollisson, 1997). Flow cytometric analysis of cells labeledwith
anti-chicken CD3 FITC MAbs (Southern Biotech, Birmingham, AL) as
described previously determined that the lymphocyte population
recovered after nylon wool separation and removal of adherent cells
was 97% positive for the expression of the T lymphocyte marker, CD3
(Bohls et al., 2006).
Ex vivo stimulation of T lymphocytes
T lymphocytes from PBMCwere stimulated ex vivowithMHC B19/
B19 (matched) and B2/B2 (mismatched) APCs. APCs at a concentra-
tion of 1×105 cells/ml in 96-well tissue culture plates were incubated
for 8 h at 39 °C, 5% CO2. APCs were infected with 1x105 ELD50 of H5N9
(A/Turkey/Wis/68) virus for 1 h followed by removal of the virus and
cells before washing 3 times with DMEM supplemented with 10% FBS.
One×106 T lymphocytes in complete RPMI were added to each well.
Cells were co-cultured for 24 h, before the media was collected and
centrifuged. The clariﬁed supernatants were used to quantify IFNγ
production by activated T lymphocytes using a nitric oxide detection
assay. At 5 weeks p.i. the pelleted T lymphocytes were collected for
FACS analysis to measure the lymphocyte proliferation. Each ex vivo
stimulation assay was conducted in duplicate.
Nitric oxide induction assay
A modiﬁed indirect IFNγ assay based on NO production (Crippen et
al., 2003; Karaca et al., 1996; Pei et al., 2003) fromHD11 cells (a chicken
macrophage cell line) was used to quantify the IFNγ secreted from ex
vivo activated T lymphocytes by APCs. Brieﬂy, cells were incubated in
individualwells of 96-well plates at a concentration of 1×105 cells/well
in complete RPMI media for 2 h at 39 °C, 5% CO2 prior to the addition of
150 μl supernatants from T lymphocyte-APCs cultures. After 24 h of
incubation, the accumulation of nitrite in supernatant from stimulated
HD11 cells was measured using the Griess reagent assay according to
the manufacturer's protocol (Sigma-Aldrich, St. Louis, MO). To ensure
that thedata represent the nitric oxide produced speciﬁcally by the IFNγ
mediated stimulation of HD11 cells and not due to any other soluble
inducing factors, nitrite concentration in each sample was normalized
by subtracting the nitrite concentration of supernatants from control
APCs cultured without T lymphocytes. The concentration of nitrite
produced was determined using sodium nitrite solutions with a
concentration of 1 to 20 μmol as standards.
FACS analysis
After ex vivo stimulationwithAIV infectedAPCs, T lymphocyteswere
collected and dual labeled with phycoerythrin-conjugated MAbs
speciﬁc for CD44 and ﬂuorescein labeled MAbs speciﬁc for either CD8
or CD4 (SouthernBiotechBirmingham,AL) as previously described (Seo
and Collisson, 1997). Flow cytometric analysis was used to determine
the concentration of T lymphocyte subpopulations. A minimum of 104
events were collected for each sample. The percentage of CD44+
lymphocytes expressing either CD4 or CD8 surface antigen was
determined using FlowJo™ (TreeStar, Inc., Ashland, OR). Cell prolifer-
ation was calculated as the percent increase in the population of CD4+
or CD8+ T lymphocytes cultured with uninfected APCs after in vitro
stimulation by virus-infected APCs for 24 h.
Statistical signiﬁcance of differences
The nitric oxide concentrations were expressed as the average of 4
to 6 birds per group. ANOVA (analysis of variance) with signiﬁcance of
p≤0.05 was used to determine statistical differences.
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